US re­sponds to drug­mak­er­s' IRA coun­terof­fers as Medicare price ne­go­ti­a­tions con­tin­ue

CMS wants fur­ther dis­cus­sions with phar­ma com­pa­nies that are par­tic­i­pat­ing in IRA price ne­go­ti­a­tions, HHS an­nounced on Tues­day.

The agency said it has re­spond­ed to coun­terof­fers pro­posed by all of the par­tic­i­pat­ing man­u­fac­tur­ers, but de­clined to com­ment fur­ther. Ac­cord­ing to CMS’ guide­lines, the agency will now hold up to three ne­go­ti­a­tion meet­ings with the com­pa­nies be­fore ne­go­ti­a­tions end Aug. 1.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER